这次会议已经有一些关于促红细胞素应用的讨论，它在美国的应用要多于欧洲，而它在西方国家的应用要比世界上其他地方更广泛。
I think while there has been some discussion at this conference about the use of erythropoietin, and it is generally used more in the U.
维生素B有助于红细胞的再生。
大多数物种中，肾脏既是促红细胞生成素的感受器官又是产生的主要场所，所以慢性肾功能衰竭会导致贫血。
In most species, the kidney is both the sensor organ and the major site of erythropoietin production, so chronic renal failure is associated with anemia.
这也是维生素b - 12缺乏的症状，B - 12是合成红细胞和DNA、维持神经系统正常运转的不可或缺的营养物质。
Those are also symptoms of a deficiency of B-12, a key nutrient needed to make red blood cells and DNA and keep the nervous system working right.
葡萄糖通过胰岛素依赖机制进入红细胞，大多数经代谢产生AT P，和还原型烟酰胺腺嘌呤二核苷酸(NADH)。
Glucose enters the RBC by an insulin-independent mechanism, and most is metabolized to produce ATP and reduced nicotinamide adenine dinucleotide (NADH).
与维生素b - 12一样，铁是血红细胞的重要组成元素。
Iron. Like vitamin B-12, iron is a crucial component of red blood cells.
巨噬细胞吞噬红细胞后破坏细胞膜，血红蛋白被转化为血红素和球蛋白。
After phagocytosis and subsequent disruption of the cell membrane, Hgb is converted to heme and globin.
只存在于动物性食物中的维生素B12缺乏，或叶酸缺乏时，机体合成的红细胞功能异常，无法为脑细胞供应至关重要的氧。
Inadequate B12, found only in animal products, or folic acid can yield blood cells unable to carry vital oxygen to the brain.
骨髓是一种红色、海绵状的东东，居住在很多大骨头的腔隙（骨髓腔）里；它需要铁元素、维生素B 12 、叶酸等原料来制造血红蛋白和红细胞。
To produce hemoglobin and red blood cells, your body needs iron, vitamin B-12, folate and other nutrients from the foods you eat.
维生素B-12：维生素B-12对制造血红细胞以及预防贫血症至关重要。
Vitamin B-12 is necessary to produce red blood cells and prevent anemia.
(营养性)巨幼细胞性贫血(维生素缺乏性贫血)为了制造足量、健康的红细胞，除了铁以外，身体还需要叶酸和维生素b12等原料。
Vitamin deficiency anemias. In addition to iron, your body needs folate and vitamin B-12 to produce sufficient Numbers of healthy red blood cells.
国际肝病：在中国促红细胞生成素的应用如何？
Hepatology Digest: What about in China and the use of erythropoietin?
目的研究癌性贫血患者血清促红细胞生成素水平及其与血红蛋白含量之间的关系。
Objective To study the relationship between levels of serum erythropoietin and haemoglobin in patients with anemia of cancer.
背景：重组体人红细胞生成素通常用于治疗贫血。
BACKGROUND: Recombinant human erythropoietin is commonly used for treatment of anaemia.
关于促红细胞生成素- A (EPO - A)应用于创伤患者治疗急性期的现存临床证据仅14篇已发表文献。
The existing evidence on the early use of EPO-A in the acute phase of trauma patients management consists of only 14 publications.
此外，在没有促红细胞生成素的血样中红细胞可以繁殖。
Moreover, erythroid colonies could be grown from blood samples without the need for exogenous erythropoietin.
促红细胞生成素是一种造血因子，临床中广泛应用于治疗各种原因造成的贫血。
Erythropoietin, the principal regulator of erythroids progenitor cells, is widely used to treat anemia caused by many diseases.
另外，这部记录片还显示，中国制药公司愿意低价出售类固醇和促红细胞生长素。
In addition, the documentary shows the readiness of Chinese pharmaceutical companies to sell steroids and the blood booster EPO at bargain prices.
因而重组促红细胞生成素对红细胞生成的刺激作用作为一种替代方法引起了人们的关注。
The stimulating effect of recombinant-erythropoietin (EPO-A) on erythropoiesis has raised interest in its administration as an alternative.
目的：探讨促红细胞生成素受体在慢性肾功能衰竭肾性贫血中的表达及意义。
Objective: to study the use of erythropoietin receptor in anemia of chronic renal failure.
促红细胞生成素与一氧化氮合酶抑制剂对肝硬化大鼠高动力循环状态的影响。
Effects of erythropoietin or nitric oxide synthesis inhibitor on hyperdynamic circulatory state in cirrhotic rats.
目的：建立红细胞胰岛素受体酪氨酸蛋白激酶(IRTK)的活性测定法。
Objective: to establish a method of detecting insulin receptor tyrosine kinase (IRTK) activity from erythrocytes.
促红细胞生成素是不容易被打破，因此它是初学者的最佳选择。
EPO is not easy to be broken, so it is the best choice for the beginners.
目的：探讨贫血患者红细胞生成素水平与血红蛋白浓度的关系。
Objective: To explore the relationship between erythropoietin level and hemoglobin concentration in patients with anemia.
结果展示人类重组红细胞生成素在早产儿贫血中应用的剂量、方法、副作用。
Results: Show the dose, methods and side effects of recombinant human erythropoietin to premature infants with anemia.
目的探讨慢性乙型肝炎(慢性乙肝)患者外周血红细胞胰岛素酶活性(EIDEA)的改变，以间接反映其肝脏胰岛素灭活功能的改变。
Objective to investigate the change of the insulin degrading enzyme activity of erythrocytes (EIDEA) in patients with chronic hepatitis b, and to reveal the ability of the liver for degrading insulin.
目的探讨慢性乙型肝炎(慢性乙肝)患者外周血红细胞胰岛素酶活性(EIDEA)的改变，以间接反映其肝脏胰岛素灭活功能的改变。
Objective to investigate the change of the insulin degrading enzyme activity of erythrocytes (EIDEA) in patients with chronic hepatitis b, and to reveal the ability of the liver for degrading insulin.
应用推荐